GlassScriptPhysician profile
Jack G Gilbey
NPI 1922093426
$926.94
in general payments reported to CMS, 2019-2025
11 companies · $364 in 2025
The $364 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.65 · 2020: $40.18 · 2021: $13.18 · 2022: $181 · 2023: $163 · 2024: $152 · 2025: $364.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $679.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $678.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $414.99 | 2022-2025 | Nucala, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $113.92 | 2019-2025 | Tezspire |
| Novartis Pharmaceuticals Corporation | $103.66 | 2022-2024 | |
| Grifols USA, LLC | $57.68 | 2022-2023 | Prolastin-C Liquid |
| Philips North America LLC | $48.94 | 2024 | (Bo0) Hosp Vent Devices |
| Insmed, INC. | $48.55 | 2023-2025 | Arikayce, Brinsupri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $40.47 | 2025 | |
| Baxter Healthcare | $33.48 | 2022-2025 | Hillrom - Vest System Model 105 Home Care |
| Viatris Specialty LLC | $25.54 | 2025 | Yupelri |
| Verona Pharma, INC. | $23.41 | 2025 | Ohtuvayre |
| Electromed, INC. | $16.30 | 2025 | Smartvest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Gilbey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.